Cite

HARVARD Citation

    Ghosal, S. et al. (2023). Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weight. ESC heart failure. pp. 1242-1249. [Online]. 
  
Back to record